+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Establishment Labs SA - Product Pipeline Analysis, 2021 Update

  • ID: 5367374
  • Company Profile
  • June 2021
  • 40 pages
  • GlobalData

FEATURED COMPANIES

  • GC Aesthetics Plc
  • Groupe Sebbin SAS
  • HANS BIOMED CORP
  • Laboratories Arion
  • Silimed Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Establishment Labs SA (Establishment Labs), a subsidiary of Establishment Labs Holdings Inc, designs, develops, manufactures and supplies medical devices and aesthetics. The company provides advanced silicone-filled breast implants and 3D (three dimensional) simulation systems, which are used in per-surgical patient consultations and planning. It also offers Puregraft which is used to remove blood, lipids, and other components from adipose tissue. The company markets its products under Motiva Implants brand name. It has operations in the US, Brazil, and Europe. Establishment Labs is headquartered in Alajuela, Costa Rica.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Establishment Labs SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • GC Aesthetics Plc
  • Groupe Sebbin SAS
  • HANS BIOMED CORP
  • Laboratories Arion
  • Silimed Inc.
Establishment Labs SA Company Overview
  • Establishment Labs SA Company Snapshot
  • Establishment Labs SA Pipeline Products and Ongoing Clinical Trials Overview
  • Establishment Labs SA - Pipeline Analysis Overview
  • Establishment Labs SA - Key Facts
  • Establishment Labs SA - Major Products and Services
  • Establishment Labs SA Pipeline Products by Development Stage
  • Establishment Labs SA Ongoing Clinical Trials by Trial Status
Establishment Labs SA Pipeline Products Overview
  • Motiva Ergonomix
  • Motiva Ergonomix Product Overview
  • Motiva Ergonomix Clinical Trial
  • Motiva Ergonomix2
  • Motiva Ergonomix2 Product Overview
  • Motiva Ergonomix2 Diamond Breast Implant
  • Motiva Ergonomix2 Diamond Breast Implant Product Overview
  • Motiva Flora Tissue Expander
  • Motiva Flora Tissue Expander Product Overview
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety Product Overview
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety Clinical Trial
  • Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety
  • Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety Product Overview
  • Motiva MIA
  • Motiva MIA Product Overview
  • Motiva MIA Clinical Trial
  • Motiva Round
  • Motiva Round Product Overview
  • Motiva Round Clinical Trial
  • SmoothSilk Anatomical Tissue Expander
  • SmoothSilk Anatomical Tissue Expander Product Overview
  • SmoothSilk Anatomical Tissue Expander Clinical Trial
Establishment Labs SA - Key Competitors

Establishment Labs SA - Key Employees

Establishment Labs SA - Locations and Subsidiaries
  • Head Office
Recent Developments
  • Establishment Labs SA, Recent Developments
  • Dec 05, 2019: ESTA reaches one million Motiva implants milestone
  • Nov 12, 2019: Establishment labs reports third quarter 2019 financial results
  • Oct 22, 2019: Establishment Labs recaps Fifth Annual World Symposium on Ergonomic Implants
  • Sep 16, 2019: Establishment Labs receives notice of allowance for key U.S. Patent application covering company’s implant surface technology and announces 510(k) submission for its tissue expander
  • Aug 13, 2019: Establishment Labs reports second quarter 2019 financial results
  • Jun 06, 2019: Establishment Labs announces appointment of Lisa Gersh to board of directors
  • May 22, 2019: Establishment Labs Holdings and Allergan Sales extend distribution and supply agreement for MotivaImagine Insertion Sleeve
  • May 15, 2019: Establishment Labs announces first quarter 2019 financial results
  • May 02, 2019: Establishment Labs to participate in Sixth Annual International Breast Surgery Workshop
  • Mar 20, 2019: Establishment Labs announces fourth quarter and full year 2018 financial results
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Establishment Labs SA Pipeline Products and Ongoing Clinical Trials Overview
  • Establishment Labs SA Pipeline Products by Equipment Type
  • Establishment Labs SA Pipeline Products by Indication
  • Establishment Labs SA Ongoing Clinical Trials by Trial Status
  • Establishment Labs SA, Key Facts
  • Establishment Labs SA, Major Products and Services
  • Establishment Labs SA Number of Pipeline Products by Development Stage
  • Establishment Labs SA Pipeline Products Summary by Development Stage
  • Establishment Labs SA Ongoing Clinical Trials by Trial Status
  • Establishment Labs SA Ongoing Clinical Trials Summary
  • Motiva Ergonomix - Product Status
  • Motiva Ergonomix - Product Description
  • Motiva Ergonomix - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
  • Motiva Ergonomix2 - Product Status
  • Motiva Ergonomix2 - Product Description
  • Motiva Ergonomix2 Diamond Breast Implant - Product Status
  • Motiva Ergonomix2 Diamond Breast Implant - Product Description
  • Motiva Flora Tissue Expander - Product Status
  • Motiva Flora Tissue Expander - Product Description
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Product Status
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Product Description
  • Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
  • Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety - Product Status
  • Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety - Product Description
  • Motiva MIA - Product Status
  • Motiva MIA - Product Description
  • Motiva MIA - A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants
  • Motiva MIA - Multicenter Study to Evaluate Motiva Mia System for Minimally Invasive Augmentation in Thailand
  • Motiva Round - Product Status
  • Motiva Round - Product Description
  • Motiva Round - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
  • SmoothSilk Anatomical Tissue Expander - Product Status
  • SmoothSilk Anatomical Tissue Expander - Product Description
  • SmoothSilk Anatomical Tissue Expander - Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery
Establishment Labs SA, Key Employees
  • Glossary
List of Figures
  • Establishment Labs SA Pipeline Products by Equipment Type
  • Establishment Labs SA Pipeline Products by Development Stage
  • Establishment Labs SA Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Silimed Inc.
  • POLYTECH Health & Aesthetics GmbH
  • Laboratories Arion
  • HANS BIOMED CORP
  • Groupe Sebbin SAS
  • GC Aesthetics Plc
Note: Product cover images may vary from those shown
Adroll
adroll